Eko Health specializes in AI-driven heart and lung disease detection through its early disease detection platform. The company's Sensora platform utilizes AI algorithms for cardiac disease detection, including identifying abnormal heart rhythms, low ejection fraction, structural heart murmurs, and AFib. By enhancing detection capabilities, Eko Health aims to reduce diagnostic bottlenecks, enabling earlier interventions and improved patient outcomes.
Market
Medical Devices
Location
San Francisco,
CA,
US
Coinvestors
ARTIS Ventures, Highland Capital Partners, NTTVC, Questa Capital, Double Point Ventures, EDBI, LG Technology Ventures